https://www.selleckchem.com/products/unc2250.html
07-3.02, P = 1.028), IPLC characteristics of squamous cell carcinoma vs. adenocarcinoma (HR = 1.89, 95% CI 1.17-3.04, P = 0.009), clinical stage II vs. stage I (HR = 2.60, 95% CI 1.08-6.27, P = 0.033), and T2 stage vs. T1 stage (HR = 1.68, 95% CI 1.04-2.72, P = 0.034) indicated worse survival. SPLC patients demonstrated a five-year survival rate of 68.6% and a five-year RMST of 49.4 months. The choice of surgical procedure (wedge resection, segmentectomy and lobectomy) for both IPLC and SPLC had no significant effect on prognosis (P >
Like
Comment
Share
